Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant VWF anticorps (AA 1815-1939)

VWF Reactivité: Humain WB, IP, IF, IHC (p) Hôte: Lapin Monoclonal VWF-1859R unconjugated Recombinant Antibody
N° du produit ABIN5646932
  • Antigène Voir toutes VWF Anticorps
    VWF (Von Willebrand Factor (VWF))
    Type d'anticorp
    Recombinant Antibody
    Épitope
    • 30
    • 16
    • 11
    • 10
    • 7
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939
    Reactivité
    • 146
    • 37
    • 26
    • 5
    • 4
    • 3
    Humain
    Hôte
    • 85
    • 78
    • 12
    • 5
    Lapin
    Clonalité
    • 91
    • 86
    • 1
    Monoclonal
    Conjugué
    • 90
    • 20
    • 15
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp VWF est non-conjugé
    Application
    • 101
    • 101
    • 68
    • 54
    • 47
    • 43
    • 24
    • 18
    • 16
    • 15
    • 14
    • 9
    • 9
    • 8
    • 8
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Purified
    Pureté
    Protein A affinity chromatography
    Immunogène
    Amino acids 1815-1939 from the human protein were used as the immunogen for this recombinant vWF antibody.
    Clone
    VWF-1859R
    Isotype
    IgG kappa
    Top Product
    Discover our top product VWF Anticorps primaire
  • Indications d'application
    The optimal dilution of the recombinant vWF antibody for each application should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Western blot: 1-2 μg/mL,Immunoprecipitation: 1-2 μg/500 μg lysate,Immunofluorescence: 1-2 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 minutes at RT

    Restrictions
    For Research Use only
  • Concentration
    0.2 mg/mL
    Buffer
    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store the recombinant vWF antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Antigène
    VWF (Von Willebrand Factor (VWF))
    Autre désignation
    von Willebrand Factor / vWF (VWF Produits)
    Synonymes
    anticorps VWF, anticorps si:ch1073-474e24.1, anticorps F8VWF, anticorps VWD, anticorps 6820430P06Rik, anticorps AI551257, anticorps B130011O06Rik, anticorps C630030D09, anticorps von Willebrand factor, anticorps Von Willebrand factor, anticorps VWF, anticorps vwf, anticorps Vwf
    Sujet
    Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
Vous êtes ici:
Support technique